Caribou Biosciences Inc • CRBU

Capital at risk.

About Caribou Biosciences Inc
Ticker
info
CRBU
Trading on
info
NASDAQ
ISIN
info
US1420381089
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Rachel E. Haurwitz Ph.D.
Headquarters
info
2929 7th Street, Berkeley, CA, United States, 94710
Employees
info
97
Website
info
https://cariboubio.com
Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Metrics
BasicAdvanced
Market cap
info
$181M
P/E ratio
info
-
EPS
info
-$1.59
Dividend Yield
info
0.00%
Beta
info
2.55
Forward P/E ratio
info
0
EBIDTA
info
$-130M
Ex dividend date
info
-
Price & volume
Market cap
info
$181M
Average daily volume
info
1.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
16.19
Price to book
info
1.48
Earnings
EPS
info
-$1.59
EPS estimate (current quarter)
info
-$0.32
EPS estimate (next quarter)
info
-$0.33
EBITDA
info
$-130M
Revenues (TTM)
info
$11.2M
Revenues per share (TTM)
info
$0.12
Technicals
Beta
info
2.55
52-week High
info
$3.54
52-week Low
info
$0.66
50-day moving average
info
$1.70
200-day moving average
info
$1.85
Short ratio
info
5.17
Short %
info
8.10%
Management effectiveness
ROE (TTM)
info
-78.97%
ROA (TTM)
info
-34.26%
Profit margin
info
0.00%
Gross profit margin
info
$-96.4M
Operating margin
info
-721.97%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
89.70%
Share stats
Outstanding Shares
info
96.6M
Float
info
92.3M
Insiders %
info
9.67%
Institutions %
info
37.70%
Analyst Insights & forecasts
info

78% Buy

22% Hold

0% Sell

Based on information from 9 analysts.

Average price target

info
$11.13
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.43
-$0.45
4.44%
Q1 • 25Beat
-$0.58
-$0.39
-48.72%
Q2 • 25Missed
-$0.30
-$0.35
14.29%
Q3 • 25Beat
-$0.28
-$0.32
13.29%
Q4 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$2.2M
$-27.5M
-1,253.32%
Q3 • 25
$3.9M
$-26.5M
-672.11%
Q4 • 25
79.30%
-3.85%
-46.37%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$195M
$53.1M
27.25%
Q3 • 25
$180M
$57.5M
31.99%
Q4 • 25
-7.87%
8.13%
17.37%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-25.2M
$10.9M
$0.3M
$-25.3M
Q3 • 25
$-20.8M
$17.8M
$4.1M
$-20.6M
Q4 • 25
-17.32%
63.62%
1,369.31%
-18.55%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Caribou Biosciences Inc share?
Collapse

Caribou Biosciences Inc shares are currently traded for undefined per share.

How many shares does Caribou Biosciences Inc have?
Collapse

Caribou Biosciences Inc currently has 96.6M shares.

Does Caribou Biosciences Inc pay dividends?
Collapse

No, Caribou Biosciences Inc doesn't pay dividends.

What is Caribou Biosciences Inc 52 week high?
Collapse

Caribou Biosciences Inc 52 week high is $3.54.

What is Caribou Biosciences Inc 52 week low?
Collapse

Caribou Biosciences Inc 52 week low is $0.66.

What is the 200-day moving average of Caribou Biosciences Inc?
Collapse

Caribou Biosciences Inc 200-day moving average is $1.85.

Who is Caribou Biosciences Inc CEO?
Collapse

The CEO of Caribou Biosciences Inc is Dr. Rachel E. Haurwitz Ph.D..

How many employees Caribou Biosciences Inc has?
Collapse

Caribou Biosciences Inc has 97 employees.

What is the market cap of Caribou Biosciences Inc?
Collapse

The market cap of Caribou Biosciences Inc is $181M.

What is the P/E of Caribou Biosciences Inc?
Collapse

The current P/E of Caribou Biosciences Inc is null.

What is the EPS of Caribou Biosciences Inc?
Collapse

The EPS of Caribou Biosciences Inc is -$1.59.

What is the PEG Ratio of Caribou Biosciences Inc?
Collapse

The PEG Ratio of Caribou Biosciences Inc is null.

What do analysts say about Caribou Biosciences Inc?
Collapse

According to the analysts Caribou Biosciences Inc is considered a buy.